Staci Arnold is an Oncology physician affiliated with Emory University. OpenAlex indexes 81 publications with 1,061 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Celgene CorporationProgram year20241 payment
- Janssen Biotech, Inc.Program year20241 payment
- bluebird bio, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2018–2022 per NIH RePORTER. The latest:
- Long-term health-related quality of life and cost of allogeneic hematopoietic cell transplantation for children with sickle cell disease
Emory University
FY2022$165,890K23HL143164 - Long-term health-related quality of life and cost of allogeneic hematopoietic cell transplantation for children with sickle cell disease
Emory University
FY2021$166,791K23HL143164 - Long-term health-related quality of life and cost of allogeneic hematopoietic cell transplantation for children with sickle cell disease
Emory University
FY2020$167,156K23HL143164
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Recommended measurement protocols for sickle cell disease in the PhenX toolkit: psychosocial factors and social determinants of health
Journal of sickle cell disease.
2025 - Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States
Annals of Internal Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Lah, MD
Emory University
Keith Delman, MD
Emory University
John Puskas, MD
Emory University
Jack Arbiser, MD
Emory University
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”